Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 1989; Volume 35,Issue 4
  • You have access
    Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.
    D C Javitt and S R Zukin
    Molecular Pharmacology April 1989, 35 (4) 387-393;
  • You have access
    Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
    R W Barrett, M E Steffey and C A Wolfram
    Molecular Pharmacology April 1989, 35 (4) 394-400;
  • You have access
    In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.
    A M Szekely, M L Barbaccia, H Alho and E Costa
    Molecular Pharmacology April 1989, 35 (4) 401-408;
  • You have access
    Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    S D Shukla, W J Morrison and A Dhar
    Molecular Pharmacology April 1989, 35 (4) 409-413;
  • You have access
    Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
    R Busche, B Tümmler, J R Riordan and D F Cano-Gauci
    Molecular Pharmacology April 1989, 35 (4) 414-421;
  • You have access
    Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
    S T Davis and S H Berger
    Molecular Pharmacology April 1989, 35 (4) 422-427;
  • You have access
    Transfer RNA is cleaved by activated bleomycin.
    R S Magliozzo, J Peisach and M R Ciriolo
    Molecular Pharmacology April 1989, 35 (4) 428-432;
  • You have access
    Use of an inducible hybrid viral gene as a model for evaluating drug effects on gene expression.
    R P Beckmann and T A Beerman
    Molecular Pharmacology April 1989, 35 (4) 433-442;
  • You have access
    Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
    T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
    Molecular Pharmacology April 1989, 35 (4) 443-449;
  • You have access
    Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor.
    M Leid, M I Schimerlik and T F Murray
    Molecular Pharmacology April 1989, 35 (4) 450-457;
  • You have access
    Aminopyridines enhance opening of calcium-activated potassium channels in GH3 anterior pituitary cells.
    M A Rogawski
    Molecular Pharmacology April 1989, 35 (4) 458-468;
  • You have access
    Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    N J Buckley, T I Bonner, C M Buckley and M R Brann
    Molecular Pharmacology April 1989, 35 (4) 469-476;
  • You have access
    The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.
    P Eveleigh, E C Hulme, C Schudt and N J Birdsall
    Molecular Pharmacology April 1989, 35 (4) 477-483;
  • You have access
    Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
    J M Zgombick, S G Beck, C D Mahle, B Craddock-Royal and S Maayani
    Molecular Pharmacology April 1989, 35 (4) 484-494;
  • You have access
    The conformational analysis of delta 9- and delta 9,11-tetrahydrocannabinols in solution using high resolution nuclear magnetic resonance spectroscopy.
    R W Kriwacki and A Makriyannis
    Molecular Pharmacology April 1989, 35 (4) 495-503;
  • You have access
    In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
    S Kubow and P G Wells
    Molecular Pharmacology April 1989, 35 (4) 504-511;
  • You have access
    Interactions between glycolysis and mixed function oxidation: studies with 7-ethoxycoumarin in perfused livers from beta-naphthoflavone-treated rats.
    S A Belinsky, F C Kauffman and R G Thurman
    Molecular Pharmacology April 1989, 35 (4) 512-518;
  • You have access
    Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase.
    D J Waxman, J J Morrissey and G A Leblanc
    Molecular Pharmacology April 1989, 35 (4) 519-525;
  • You have access
    Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.
    C P Berrie, P T Hawkins, L R Stephens, T K Harden and C P Downes
    Molecular Pharmacology April 1989, 35 (4) 526-532;
  • You have access
    Solubilization and characterization of pituitary thyrotropin-releasing hormone receptors.
    W J Phillips and P M Hinkle
    Molecular Pharmacology April 1989, 35 (4) 533-540;
  • You have access
    Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    X Y Wei, A Rutledge and D J Triggle
    Molecular Pharmacology April 1989, 35 (4) 541-552;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 35, Issue 4
1 Apr 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics